---
figid: PMC7665128__ijms-21-08410-g003
figlink: pmc/articles/PMC7665128/figure/ijms-21-08410-f003/
number: F3
caption: 'Schematic action of ketamine on mTOR pathway. Ketamine blockade of NMDARs
  on tonic firing GABA interneurons results in disinhibition of glutamate transmission
  causing a subsequent glutamate burst. This rapid glutamate burst activates AMPARs
  and leads to subsequent Ca2+ influx through L-type voltage-dependent Ca2+ channels
  (VDCCs). Ca2+ promotes BDNF release, which acts via Tropomyosin receptor kinase
  B/Protein kinase B (TrkB-Akt) to stimulate mTOR signalling. The different effects
  are linked with mTORC1 and mTORC2 activity. mTORC1, by phosphorylation, activates
  the ribosomal protein S6 kinase (S6K), as well as represses the inhibitory 4E binding
  proteins (4E-PB). This concert of events increases the translation of synaptic proteins
  (PSD95, synapsin-1, GluA1, GluA2) promoting synaptogenesis and intensifying translation
  of BDNF. Akt/PKB and PKC isoforms are the main substrates regulated by mTORC2. PKC-dependent phosphorylation of the growth-associated protein 43 (GAP43) and MARKS plays an important role in rearrangement of actin cytoskeleton and synaptic transmission. Close relation between GAP43 and calcium-binding protein - calmodulin (CaM) also affects several Ca2+/CaM-regulated neuronal processes. Additionally, AKT/PKB can phosphorylate the mTORC1 augmenting it activation.'
pmcid: PMC7665128
papertitle: Ketamine and Calcium Signaling—A Crosstalk for Neuronal Physiology and
  Pathology.
reftext: Malwina Lisek, et al. Int J Mol Sci. 2020 Nov;21(21):8410.
pmc_ranked_result_index: '76374'
pathway_score: 0.9308024
filename: ijms-21-08410-g003.jpg
figtitle: Schematic action of ketamine on mTOR pathway
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7665128__ijms-21-08410-g003.html
  '@type': Dataset
  description: Schematic action of ketamine on mTOR pathway. Ketamine blockade of
    NMDARs on tonic firing GABA interneurons results in disinhibition of glutamate
    transmission causing a subsequent glutamate burst. This rapid glutamate burst
    activates AMPARs and leads to subsequent Ca2+ influx through L-type voltage-dependent
    Ca2+ channels (VDCCs). Ca2+ promotes BDNF release, which acts via Tropomyosin
    receptor kinase B/Protein kinase B (TrkB-Akt) to stimulate mTOR signalling. The
    different effects are linked with mTORC1 and mTORC2 activity. mTORC1, by phosphorylation,
    activates the ribosomal protein S6 kinase (S6K), as well as represses the inhibitory
    4E binding proteins (4E-PB). This concert of events increases the translation
    of synaptic proteins (PSD95, synapsin-1, GluA1, GluA2) promoting synaptogenesis
    and intensifying translation of BDNF. Akt/PKB and PKC isoforms are the main substrates
    regulated by mTORC2. PKC-dependent phosphorylation of the growth-associated protein
    43 (GAP43) and MARKS plays an important role in rearrangement of actin cytoskeleton
    and synaptic transmission. Close relation between GAP43 and calcium-binding protein
    - calmodulin (CaM) also affects several Ca2+/CaM-regulated neuronal processes.
    Additionally, AKT/PKB can phosphorylate the mTORC1 augmenting it activation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BDNF
  - NTRK2
  - AKT2
  - AKT3
  - AKT1
  - PRKCA
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCQ
  - PRKCB
  - PRKCD
  - PRKCI
  - PRKCZ
  - PRKD3
  - DLG4
  - KRIT1
  - Glutamate
  - Ketamine
  - Ca2+
  - CaM
genes:
- word: BDNF
  symbol: BDNF
  source: hgnc_symbol
  hgnc_symbol: BDNF
  entrez: '627'
- word: TrkB
  symbol: TRKB
  source: hgnc_alias_symbol
  hgnc_symbol: NTRK2
  entrez: '4915'
- word: BDNF
  symbol: BDNF
  source: hgnc_symbol
  hgnc_symbol: BDNF
  entrez: '627'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt/PKB
  symbol: PKB
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt/PKB
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt/PKB
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt/PKB
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: РКС
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: РКС
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: РКС
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: РКС
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: РКС
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: РКС
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: РКС
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: РКС
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: РКС
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: РКС
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: (PSD-95,
  symbol: PSD95
  source: hgnc_alias_symbol
  hgnc_symbol: DLG4
  entrez: '1742'
- word: (GAP43/CaM)
  symbol: CAM
  source: hgnc_alias_symbol
  hgnc_symbol: KRIT1
  entrez: '889'
chemicals:
- word: Glutamate
  source: ''
  identifier: ''
- word: Ketamine
  source: MESH
  identifier: D007649
- word: Ca2+
  source: MESH
  identifier: D002118
- word: CaM
  source: MESH
  identifier: D002118
diseases: []
figid_alias: PMC7665128__F3
redirect_from: /figures/PMC7665128__F3
figtype: Figure
---
